Vifor Pharma, a world leading Nephrology, Iron Deficiency and Cardio-Renal pharmaceutical company, is experiencing rapid growth due to pipeline realization and optimization.
We are currently looking for a Global Business Planning & Market Insights Lead – Rare Diseases in our Global Commercial Excellence Team based in Glattbrugg. In this role you will be responsible for driving the strategic & tactical analysis plan for specific launch and pipeline products within our Rare Disease portfolio, with the goal of generating actionable insights for the business.
This role will require a high level of cross functional interaction, particularly with the Global Brand Teams, with whom you will be a trusted partner. As such, you will be a great communicator, able to move between technical and non-technical discussions, as well as being able to translate business needs into actionable items.
You will ideally have experience within primary market research, forecasting and competitive intelligence within an innovative pharmaceutical / biotech/ consultancy environment. Key drivers must be business excellence and thriving in a lean but motivated group.
Your tasks and responsibilities will include, but not be limited to:
The Vifor Pharma Group is a global specialty pharmaceuticals company. It aims to become the global leader in iron deficiency, nephrology and cardio-renal therapies. The company is the partner of choice for pharmaceuticals and innovative patient-focused solutions. Vifor Pharma Group strives to help patients around the world with severe and chronic diseases lead better, healthier lives. The company develops, manufactures and markets pharmaceutical products for precision patient care. Vifor Pharma Group holds a leading position in all its core business activities and consists of the following companies: Vifor Pharma; Vifor Fresenius Medical Care Renal Pharma (a joint company with Fresenius Medical Care); and OM Pharma.
Vifor Pharma Group is headquartered in Switzerland, and listed on the Swiss Stock Exchange (SIX Swiss Exchange, VIFN, ISIN: CH0364749348).
For more information, please visit www.viforpharma.com/career